Company patents
Ypsomed AG
Ypsomed AG's patent strategy is heavily concentrated in Drug Delivery Devices, representing 94.8% of its portfolio, which saw a significant surge in 2024 with 43 patents (YoY +95.5%) before a decline in 2025 and so far in 2026. Surprisingly, despite a strong focus on medical devices, the company has shown a shifting priority in Healthcare Informatics, with a 14.3% decline in 2025 and a sharp drop so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
116 US filings (since 2023) · 4 categories · 4 themes
Mechanical or electromechanical systems designed for precise, often self-administered, delivery of medicaments, including features for dose setting, needle insertion/retraction, and safety mechanisms to prevent premature activation.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Patents
Showing 1-10 of 174